Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A real-world, non-interventional, prospective study of the effectiveness and safety of apremilast in bio-naïve adults with moderate plaque psoriasis treated in the routine care in Greece - the 'APRAISAL' study.
Ioannides D, Antonakopoulos N, Chasapi V, Oikonomou C, Tampouratzi E, Lazaridou E, Rigopoulos D, Neofotistou O, Drosos A, Anastasiadis G, Rovithi E, Kalinou C, Papadavid E, Aronis P, Papageorgiou M, Protopapa A, Bassukas I, Lefaki I, Zafiriou E, Krasagakis K, Pokas E, Anagnostopoulos Z, Kekki A, Papakonstantis M. Ioannides D, et al. Among authors: papakonstantis m. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2055-2063. doi: 10.1111/jdv.18166. Epub 2022 May 21. J Eur Acad Dermatol Venereol. 2022. PMID: 35451115
Effectiveness and safety of apremilast in biologic-naïve patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study.
Ioannides D, Antonakopoulos N, Georgiou S, Chasapi V, Katsantonis I, Drosos A, Rigopoulos D, Antoniou C, Anastasiadis G, Bassukas I, Ioannidou D, Protopapa A, Neofotistou O, Krasagakis K, Aronis P, Papageorgiou M, Lazaridou E, Patsatsi A, Lefaki I, Roussaki-Schulze AV, Satra F, Anagnostopoulos Z, Papakonstantis M. Ioannides D, et al. Among authors: papakonstantis m. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):1838-1848. doi: 10.1111/jdv.17392. Epub 2021 Jul 13. J Eur Acad Dermatol Venereol. 2021. PMID: 34036627
Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals.
Tampouratzi E, Papakonstantis M, Katsantonis J, Sidiropoulos T, Delli F, Efthymiadis K, Sfaelos K, Christodoulou A, Chasapi V, Panagakis P. Tampouratzi E, et al. Among authors: papakonstantis m. Dermatol Ther. 2022 Jul;35(7):e15532. doi: 10.1111/dth.15532. Epub 2022 May 30. Dermatol Ther. 2022. PMID: 35451147
Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study.
Rigopoulos D, Angelakopoulos C, Apalla Z, Georgiou S, Delli F, Drosos A, Zafiriou E, Katsantonis J, Lazaridou E, Panagakis P, Papadavid E, Papakonstantis M, Roussaki-Schulze AV, Sotiriou E, Anastasiadis G, Tampouratzi E, Chasapi V, Sfaelos K, Ioannides D; BrIDGE Study Group. Rigopoulos D, et al. Among authors: papakonstantis m. Dermatol Ther. 2022 Dec;35(12):e15886. doi: 10.1111/dth.15886. Epub 2022 Nov 1. Dermatol Ther. 2022. PMID: 36184757
Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).
Rigopoulos D, Tampouratzi E, Angelakopoulos C, Apalla Z, Barkis I, Georgiou S, Delli F, Drosos A, Zafiriou E, Katsantonis J, Lazaridou E, Panagakis P, Papadavid E, Papakonstantis M, Roussaki-Schulze AV, Sotiriou E, Anastasiadis G, Chasapi V, Sfaelos K, Ioannides D; BrIDGE Study Group. Rigopoulos D, et al. Among authors: papakonstantis m. J Eur Acad Dermatol Venereol. 2024 Feb 3. doi: 10.1111/jdv.19816. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38308561
Topical prebiotics/postbiotics and PRURISCORE validation in atopic dermatitis. International study of 396 patients.
Gelmetti C, Rigoni C, Cantù AM; members of the Italian Groupb (in alphabetical order):; Agolzer A, Agrusa A, Brena M, Dall'Oglio F, Demichelis P, Farina S, Frasin LA, Lorenzi S, Mazzola G, Praticò M, Robotti S, Tedeschi A, Villa L; members of the international “ad hoc” Group; (in alphabetical order):; Ananiadis P, Arkoumani E, Astashonok I, Baselga Torres E, Borici S, Cano E, Cela R, Cengo A, Corella F, Cubiro Raventos X, De Jesus Silva MA, Demiraj E, Dhima E, Doci X, Domarad A, Didyk M, Dyli A, Efthimiou O, Filippi G, Flores Climente VA, Garcia Muret MP, Navarro JG, Gega M, Giakoub AN, Giakoubis V, Gica A, Gjomema M, Guri B, Janushaj E, Kanelleas A, Kanelopoulou G, Kapaj E, Kapoukranidou D, Karadima K, Katsavou A, Kotrulja L, Kyriakou A, Larios G, Lopez A, Lopez C, Manoli SM, Matvienko T, Mervic L, Mileounis K, Muja D, Nadezhda M, Panagioti D, Papakonstantis M, Papanikou M, Papathemeli D, Papigkioti K, Pivak V, Preza D, Roé E, Rogl Butina M, Serra Baldrich E, Sgouros D, Shilova A, Shllaku E, Sideris N, Sina E, Sinani A, Sourli-Chasioti F, Stankaj M, Tasioula D, Tsalmadoupis A, Tsatsou F, Tsenebi E, Tsitlakidou A, Vassis P, Vilarrassa E, Vorobey O, Voutsakis N, Yakovleva S,… See abstract for full author list ➔ Gelmetti C, et al. Among authors: papakonstantis m. J Dermatolog Treat. 2023 Dec;34(1):2131703. doi: 10.1080/09546634.2022.2131703. Epub 2022 Oct 17. J Dermatolog Treat. 2023. PMID: 36205596 Free article.